Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Alexopoulos

Showing results (61-70 of 387) with videos related to

Pageof 39
Sort By:
Expert Review of Cardiovascular Therapy|October 5, 2019
P2Y12 inhibitors for the treatment of acute coronary syndrome patients undergoing percutaneous coronary intervention: current understanding and outcomesDimitrios Alexopoulos, Charalampos Varlamos, Aikaterini Mpahara, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 13, 2017
Cangrelor in Percutaneous Coronary Intervention: Current Status and PerspectivesDimitrios Alexopoulos, Christos Pappas, Danai Sfantou, et al.
The Canadian Journal of Cardiology|September 18, 2010
Double-barrel stenting of distal left main stenosis in a patient with acute coronary syndrome: intravascular ultrasound and optical coherence tomography follow-up at six monthsAnastasia Damelou, Periklis Davlouros, Vasileios Karantalis, et al.
Journal of Cardiovascular Electrophysiology|April 12, 2013
Ischemia-triggered pause-dependent polymorphous ventricular tachycardia storm complicating acute myocardial infarction terminated by complete coronary reperfusionJohn Chiladakis, Fani Zagkli, Konstantinos Chouchoulis, et al.
International Journal of Cardiology|April 9, 2011
Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAXGeorge Hahalis, George Dangas, Periklis Davlouros, et al.
Revista Espanola De Cardiologia (English Ed.)|June 28, 2016
One-year Non-persistence With Contemporary Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary InterventionJohn Goudevenos, Ioanna Xanthopoulou, Spyridon Deftereos, et al.
Platelets|October 13, 2017
Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?Dimitrios Alexopoulos, Konstantinos Katogiannis, Danai Sfantou, et al.
International Journal of Cardiology|May 27, 2015
Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: Ready for prime time?Dimitrios Alexopoulos, Athanasios Moulias, Ioannis Kanakakis, et al.
Journal of the American College of Cardiology|September 10, 2016
Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?Dimitrios Alexopoulos, Ioanna Xanthopoulou, Athanasios Moulias, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 15, 2020
Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionDespoina-Rafailia Benetou, Charalampos Varlamos, Aikaterini Mpahara, et al.
Pageof 39

Showing results (61-70 of 387) with videos related to

Sort By:
Pageof 39
Expert Review of Cardiovascular Therapy|October 5, 2019
P2Y12 inhibitors for the treatment of acute coronary syndrome patients undergoing percutaneous coronary intervention: current understanding and outcomesDimitrios Alexopoulos, Charalampos Varlamos, Aikaterini Mpahara, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 13, 2017
Cangrelor in Percutaneous Coronary Intervention: Current Status and PerspectivesDimitrios Alexopoulos, Christos Pappas, Danai Sfantou, et al.
The Canadian Journal of Cardiology|September 18, 2010
Double-barrel stenting of distal left main stenosis in a patient with acute coronary syndrome: intravascular ultrasound and optical coherence tomography follow-up at six monthsAnastasia Damelou, Periklis Davlouros, Vasileios Karantalis, et al.
Journal of Cardiovascular Electrophysiology|April 12, 2013
Ischemia-triggered pause-dependent polymorphous ventricular tachycardia storm complicating acute myocardial infarction terminated by complete coronary reperfusionJohn Chiladakis, Fani Zagkli, Konstantinos Chouchoulis, et al.
International Journal of Cardiology|April 9, 2011
Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAXGeorge Hahalis, George Dangas, Periklis Davlouros, et al.
Revista Espanola De Cardiologia (English Ed.)|June 28, 2016
One-year Non-persistence With Contemporary Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary InterventionJohn Goudevenos, Ioanna Xanthopoulou, Spyridon Deftereos, et al.
Platelets|October 13, 2017
Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?Dimitrios Alexopoulos, Konstantinos Katogiannis, Danai Sfantou, et al.
International Journal of Cardiology|May 27, 2015
Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: Ready for prime time?Dimitrios Alexopoulos, Athanasios Moulias, Ioannis Kanakakis, et al.
Journal of the American College of Cardiology|September 10, 2016
Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?Dimitrios Alexopoulos, Ioanna Xanthopoulou, Athanasios Moulias, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 15, 2020
Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionDespoina-Rafailia Benetou, Charalampos Varlamos, Aikaterini Mpahara, et al.
Pageof 39